67.2 Chronic Malaise, Fatigue & ME/CFS
Key Takeaways
- Fatigue appears in roughly 20 to 30 percent of primary care encounters, and the most frequent identifiable contributors are psychiatric, sleep-related, and pharmacologic rather than occult malignancy.
- Sorting the complaint into fatigue, objective weakness, somnolence, exertional dyspnea, or anhedonia narrows the differential more effectively than any laboratory panel.
- A defensible initial panel is CBC, comprehensive metabolic panel, TSH, ferritin, HIV, and urinalysis, paired with PHQ-9, GAD-7, medication reconciliation, and sleep-apnea screening; broad ANA, EBV, and non-endemic Lyme testing have poor yield.
- The 2015 National Academy of Medicine criteria for ME/CFS require more than 6 months of substantial activity reduction, post-exertional malaise, and unrefreshing sleep, plus either cognitive impairment or orthostatic intolerance.
- Post-exertional malaise — disproportionate symptom worsening typically delayed 12 to 48 hours after exertion — is the discriminating feature, and management centers on pacing rather than graded exercise therapy.
The Most Common Complaint Without a Diagnosis
Fatigue is among the ten most common presenting complaints in ambulatory family medicine, appearing in roughly 20 to 30 percent of primary care encounters as a primary or secondary concern. It is also the complaint most likely to end without an organic diagnosis: after a thorough evaluation, no specific medical cause is identified in a substantial minority of patients, and the most frequent identifiable contributors are psychiatric, sleep-related, and pharmacologic rather than occult malignancy.
The ABFM blueprint carries malaise and fatigue as a Chronic Care Management activity, which frames the task correctly. The board question is rarely "what rare disease is this?" It is usually "which limited set of investigations is appropriate, and which shotgun panel is not?"
Defining the terms
| Term | Meaning | Discriminating question |
|---|---|---|
| Fatigue | Subjective lack of energy; difficulty initiating or sustaining activity | "Are you too tired to start?" |
| Weakness | Objective loss of muscle power | "Can you rise from a chair without using your arms?" |
| Somnolence | Propensity to fall asleep | "Do you doze off watching television or at red lights?" |
| Dyspnea on exertion | Breathlessness limiting activity | "What stops you — breath or energy?" |
| Anhedonia | Loss of interest and pleasure | PHQ-9 items 1 and 2 |
Sorting the complaint into one of these five buckets does more diagnostic work than any laboratory panel. True proximal weakness points toward myopathy, thyroid disease, or corticosteroid excess; somnolence points toward sleep-disordered breathing or medication effect; anhedonia points toward depression.
Duration matters
- Recent (< 1 month): usually acute illness, medication change, situational stress, or sleep loss.
- Prolonged (1 to 6 months): broaden the evaluation.
- Chronic (> 6 months): consider myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and post-viral syndromes alongside the standard differential.
A Working Differential
CHRONIC FATIGUE — SYSTEMS DIFFERENTIAL
PSYCHIATRIC Major depression, generalized anxiety, somatic symptom disorder
(most common -> PHQ-9, GAD-7 on every fatigue evaluation
identifiable)
SLEEP Obstructive sleep apnea, chronic insomnia, restless legs,
insufficient sleep syndrome, shift work disorder
MEDICATION / Beta blockers, antihistamines, opioids, benzodiazepines,
SUBSTANCE gabapentinoids, antipsychotics, statins (myalgia), alcohol,
cannabis, stimulant withdrawal
ENDOCRINE / Hypothyroidism, diabetes mellitus, adrenal insufficiency,
METABOLIC hypercalcemia, chronic kidney disease, hyponatremia
HEMATOLOGIC Iron deficiency (with or without anemia), B12/folate
deficiency, hemoglobinopathy, malignancy
CARDIOPULMONARY Heart failure, coronary disease, COPD, interstitial lung
disease, pulmonary hypertension, deconditioning
INFECTIOUS HIV, hepatitis B and C, tuberculosis, infectious
mononucleosis, Lyme disease, post-COVID condition
INFLAMMATORY Rheumatoid arthritis, SLE, polymyalgia rheumatica,
inflammatory bowel disease, celiac disease
NEOPLASTIC Any malignancy; suspect when paired with red flags
Red flags that redirect the workup
- Unintentional weight loss (> 5% of body weight in 6 to 12 months)
- Fever, drenching night sweats, or persistent lymphadenopathy
- New or progressive dyspnea, chest pain, or syncope
- Focal neurologic deficit, or objective proximal weakness
- New fatigue in an adult older than 65, or fatigue accompanied by anemia
- Overdue age-appropriate cancer screening
Evaluation: A Targeted Panel, Not a Shotgun
History and examination drive testing. A reasonable initial laboratory set for prolonged unexplained fatigue is small and defensible:
| Test | What it captures |
|---|---|
| CBC with differential | Anemia, cytopenias, leukocytosis, lymphocytosis |
| Comprehensive metabolic panel | Glucose, sodium, calcium, creatinine, transaminases, albumin |
| TSH | Hypothyroidism (reflex free T4 if abnormal) |
| Ferritin / iron studies | Iron deficiency, which causes fatigue before anemia appears |
| HIV (and hepatitis C once in adulthood) | Treatable infectious causes with nonspecific presentations |
| Urinalysis | Renal disease, glycosuria, infection |
| ESR or CRP | Non-specific but useful when inflammatory disease is plausible |
Add B12 and folate, celiac serology (tissue transglutaminase IgA with total IgA), morning cortisol, A1c, or chest imaging only when specific features justify them.
[!IMPORTANT] What not to order. Routine broad autoimmune panels (ANA, rheumatoid factor), Epstein-Barr virus serologic panels, "chronic Lyme" testing outside endemic exposure, adrenal fatigue panels, heavy metal screens, and food sensitivity IgG testing have poor yield in undifferentiated fatigue and generate false positives that produce cascades of further testing. Ordering an ANA on an otherwise well patient with isolated fatigue is a recurring wrong answer.
Every fatigue evaluation should include a PHQ-9 and GAD-7, a complete medication and supplement reconciliation, a substance-use history, and screening questions for sleep-disordered breathing — these four steps identify more causes than the laboratory panel does.
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
In 2015 the Institute of Medicine (now the National Academy of Medicine) published diagnostic criteria that replaced the older, more restrictive definitions and proposed the alternative name systemic exertion intolerance disease (SEID). The criteria are clinical and positive — ME/CFS is a diagnosis made by findings, not merely by exclusion.
All three of the following are required:
- A substantial reduction or impairment in the ability to engage in pre-illness levels of occupational, educational, social, or personal activities that persists for more than 6 months and is accompanied by fatigue that is often profound, is of new or definite onset (not lifelong), is not the result of ongoing excessive exertion, and is not substantially alleviated by rest;
- Post-exertional malaise (PEM);
- Unrefreshing sleep.
Plus at least one of the two following manifestations:
- Cognitive impairment ("brain fog"), or
- Orthostatic intolerance (symptoms worsening on standing, improving on recumbency).
Symptoms should be present at least half of the time with at least moderate intensity.
Post-exertional malaise is the discriminating feature
PEM is the disproportionate worsening of symptoms after physical, cognitive, or emotional exertion, typically delayed by 12 to 48 hours and lasting days or longer. Ordinary deconditioning improves with activity; PEM predictably worsens with it. Eliciting PEM specifically ("What happens the day after you push yourself?") separates ME/CFS from depression-related fatigue and from deconditioning.
Management principles
- Pacing / energy envelope management is the cornerstone: activity is planned to stay within the threshold that triggers PEM.
- Graded exercise therapy is no longer recommended as a curative treatment; the UK NICE 2021 guideline removed it after evidence review, and prescribing escalating exercise irrespective of PEM can worsen the illness.
- Treat what is treatable: orthostatic intolerance (fluids, salt, compression), sleep disturbance, pain, and comorbid depression or anxiety — while making clear that comorbid depression is not the explanation for the illness.
- Validate the diagnosis. Repeated negative testing without a name is itself harmful; ME/CFS is a recognized diagnosis, and naming it improves function and reduces unnecessary investigation.
- Post-COVID condition (long COVID) overlaps substantially with ME/CFS and is evaluated and managed along the same lines when PEM is present.
Board Exam Traps
- Isolated fatigue with a normal examination → targeted panel plus PHQ-9, medication review, and sleep screening. Not an ANA, not an EBV panel, not a "chronic Lyme" test.
- Fatigue with normal hemoglobin but ferritin of 12 ng/mL → iron deficiency without anemia is a genuine and treatable cause; treat and reassess.
- Fatigue plus proximal weakness and elevated creatine kinase in a statin user → statin-associated muscle symptoms or an inflammatory myopathy, not undifferentiated fatigue.
- Six months of profound fatigue, unrefreshing sleep, brain fog, and symptoms that flare 24 hours after exertion → ME/CFS by the 2015 National Academy of Medicine criteria; the answer is pacing, not graded exercise therapy.
- Fatigue plus weight loss, night sweats, and adenopathy → red flags mandate imaging and directed evaluation, not reassurance.
- Sleepy rather than fatigued, with snoring and a BMI of 36 → evaluate for obstructive sleep apnea before an extensive metabolic workup.
A 34-year-old woman reports 8 months of profound fatigue that began after an acute febrile illness. She sleeps 9 hours nightly and wakes unrefreshed, describes word-finding difficulty, and states that any attempt at moderate exercise leaves her bedbound for 2 days beginning the following morning. Physical examination, CBC, comprehensive metabolic panel, TSH, ferritin, and HIV testing are all normal. PHQ-9 is 6. Which feature most strongly supports a diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome?
A 47-year-old man presents with 4 months of fatigue. He has no weight loss, fever, night sweats, or adenopathy, takes no medications, drinks alcohol socially, and has a normal physical examination. Which of the following initial evaluations is most appropriate?
A 29-year-old woman with established myalgic encephalomyelitis/chronic fatigue syndrome asks about an exercise program. Which management approach is most consistent with current guidance?